Decibel Announces Stock Option Grants

Rhea-AI Summary

Decibel Cannabis Company (TSXV: DB) (OTCQB: DBCCF) has granted 21,915,974 stock options to officers and employees as part of its long-term compensation and retention program. The options are exercisable at either $0.13 or $0.075 per share, with one tranche vesting immediately and remaining tranches vesting in three equal nine-month installments starting October 21, 2025. All options will expire on January 21, 2028.

The company, known for premium cannabis brands like General Admission, Qwest, and Vox, recently expanded its operations through the acquisition of AgMedica Biosciences in Q4 2024, adding an EU-GMP-certified facility. Decibel currently operates three cultivation facilities and a processing and manufacturing center, strengthening its position in high-quality cannabis products with global distribution potential.

Positive

• Addition of EU-GMP-certified facility through AgMedica acquisition enhances global distribution capabilities
• Operation of three cultivation facilities and processing center indicates strong production capacity
• Employee retention program implementation through stock options suggests strategic talent management

Negative

• Potential shareholder dilution from issuance of 21.9 million stock options
• Multiple exercise prices ($0.13 and $0.075) may indicate price uncertainty

CALGARY, AB, Jan. 21, 2025 /PRNewswire/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, announces that it has granted an aggregate of 21,915,974 stock options (each, an "Option") to certain officers and employees of the Company in accordance with the Company's stock option plan.

Each Option is exercisable for one common share in the capital of the Company (a "Share") at a price of either $0.13 or $0.075 per Share, depending on the grant. This is a normal-course grant that comprises part of the long-term compensation and employee retention incentives program provided by the Company. One tranche of the Options will vest as of the date hereof, while the remaining tranches will vest in three equal nine (9) month installments commencing on October 21, 2025, with all of the Options expiring on January 21, 2028.

About Decibel

Decibel is a consumer-focused cannabis company known for premium products that delight customers through innovation and quality. With brands like General Admission, Qwest, and Vox, Decibel's offerings are available across Canada, with expanding reach into global markets. Following the acquisition of AgMedica Biosciences in Q4 2024, Decibel has added an EU-GMP-certified facility, supporting its commitment to international standards and global distribution growth. Decibel now operates three cultivation facilities and a processing and manufacturing center, positioning the company as a leader in high-quality, globally accessible cannabis products and brands.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation, including statements that relate to Decibel's business plans generally, and specifically the creation of a global footprint and ability to delight customers through a commitment to robust innovation and product quality. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, the Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.  Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Many of these risks and uncertainties and additional risk factors generally applicable to the Company are described in the Company's management's discussion and analysis for the three and nine months ended September 30, 2024 and 2023, which are available under the Company's profile at www.sedarplus.ca.

View original content to download multimedia:https://www.prnewswire.com/news-releases/decibel-announces-stock-option-grants-302355733.html

SOURCE Decibel Cannabis Company Inc.

FAQ

How many stock options did Decibel Cannabis (DBCCF) grant in January 2025?

Decibel Cannabis granted 21,915,974 stock options to officers and employees in January 2025.

What are the exercise prices for Decibel's (DBCCF) January 2025 stock options?

The stock options are exercisable at either $0.13 or $0.075 per share, depending on the grant.

When do Decibel's (DBCCF) January 2025 stock options expire?

The stock options will expire on January 21, 2028.

What is the vesting schedule for Decibel's (DBCCF) 2025 stock options?

One tranche vests immediately, with remaining tranches vesting in three equal nine-month installments starting October 21, 2025.

How many facilities does Decibel Cannabis (DBCCF) operate after the AgMedica acquisition?

Decibel operates three cultivation facilities and one processing and manufacturing center.